XRTX
XORTX Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.94 / 10
Underperform
XORTX Therapeutics' fundamental analysis yields a 2.9/10 score, reflecting several weaknesses: Days Sales Outstanding is high at 72.55, indicating slow receivable collection; Profit-MV is positive but other metrics like PB-ROE and Asset-MV are negative or low. Revenue growth is strong YoY, yet this is offset by poor coverage ratios and asset efficiency. Overall, financial health is subpar, leading to an 'Underperform' rating.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
PB-ROE
Value0.04
Score1/3
Weight19.97%
1M Return9.57%
Value0.04
Score1/3
Weight19.97%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
PB-ROE
Value0.04
Score1/3
Weight19.97%
1M Return9.57%
Value0.04
Score1/3
Weight19.97%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Is XRTX undervalued or overvalued?
- XRTX scores 2.94/10 on fundamentals and holds a Premium valuation at present. Backed by its -77.81% ROE, 0.00% net margin, -1.19 P/E ratio, 1.17 P/B ratio, and -433.33% earnings growth, these metrics solidify its Underperform investment rating.
